Public support for harm reduction: A population survey of Canadian adults.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 23 10 2020
accepted: 05 05 2021
entrez: 19 5 2021
pubmed: 20 5 2021
medline: 27 10 2021
Statut: epublish

Résumé

We described public views toward harm reduction among Canadian adults and tested a social exposure model predicting support for these contentious services, drawing on theories in the morality policy, intergroup relations, addiction, and media communication literatures. A quota sample of 4645 adults (18+ years), randomly drawn from an online research panel and stratified to match age and sex distributions of adults within and across Canadian provinces, was recruited in June 2018. Participants completed survey items assessing support for harm reduction for people who use drugs (PWUD) and for seven harm reduction interventions. Additional items assessed exposure to media coverage on harm reduction, and scales assessing stigma toward PWUD (α = .72), personal familiarity with PWUD (α = .84), and disease model beliefs about addiction (α = .79). Most (64%) Canadians supported harm reduction (provincial estimates = 60% - 73%). Five of seven interventions received majority support, including: outreach (79%), naloxone (72%), drug checking (70%), needle distribution (60%) and supervised drug consumption (55%). Low-threshold opioid agonist treatment and safe inhalation interventions received less support (49% and 44%). Our social exposure model, adjusted for respondent sex, household income, political views, and education, exhibited good fit and accounted for 17% of variance in public support for harm reduction. Personal familiarity with PWUD and disease model beliefs about addiction were directly associated with support (βs = .07 and -0.10, respectively), and indirectly influenced public support via stigmatized attitudes toward PWUD (βs = 0.01 and -0.01, respectively). Strategies to increase support for harm reduction could problematize certain disease model beliefs (e.g., "There are only two possibilities for an alcoholic or drug addict-permanent abstinence or death") and creating opportunities to reduce social distance between PWUD, the public, and policy makers.

Identifiants

pubmed: 34010338
doi: 10.1371/journal.pone.0251860
pii: PONE-D-20-33401
pmc: PMC8133460
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0251860

Subventions

Organisme : CIHR
ID : MOP 137073
Pays : Canada

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Urban Health. 2008 Nov;85(6):812-25
pubmed: 18758964
Int J Drug Policy. 2009 Jan;20(1):4-13
pubmed: 18554896
J Pers Soc Psychol. 2006 May;90(5):751-83
pubmed: 16737372
Drug Alcohol Depend. 2013 Jul 1;131(1-2):23-35
pubmed: 23490450
BMC Health Serv Res. 2016 Feb 13;16:52
pubmed: 26873360
Addiction. 2014 Jun;109(6):946-53
pubmed: 24520984
Int J Drug Policy. 2007 Jan;18(1):54-61
pubmed: 17689344
Subst Abuse Treat Prev Policy. 2016 Feb 09;11:8
pubmed: 26860540
Lancet. 2012 Jan 7;379(9810):71-83
pubmed: 22225672
Science. 1997 Oct 3;278(5335):45-7
pubmed: 9311924
Int J Drug Policy. 2007 Jan;18(1):46-53
pubmed: 17689343
Int J Drug Policy. 2019 Sep;71:142-149
pubmed: 30711412
Subst Abuse Treat Prev Policy. 2013 Dec 01;8:40
pubmed: 24289280
Drug Alcohol Rev. 2007 Jul;26(4):355-61
pubmed: 17564870
Subst Abuse Treat Prev Policy. 2015 Jun 30;10:25
pubmed: 26122408
Schizophr Bull. 2001;27(2):219-25
pubmed: 11354589
Harm Reduct J. 2010 May 25;7:11
pubmed: 20500870
CMAJ. 2004 Sep 28;171(7):731-4
pubmed: 15451834
Drug Alcohol Rev. 2006 Nov;25(6):611-24
pubmed: 17132577
J Urban Health. 2012 Aug;89(4):678-96
pubmed: 22585448
Harm Reduct J. 2017 Jul 26;14(1):50
pubmed: 28747183
Health Place. 2012 Mar;18(2):152-62
pubmed: 21955638
Int J Drug Policy. 2017 Jul;45:9-17
pubmed: 28454045
Drug Alcohol Depend. 2019 Dec 1;205:107599
pubmed: 31610295
Psychiatr Serv. 2001 Jul;52(7):953-8
pubmed: 11433114
Prev Med. 2018 Jun;111:73-77
pubmed: 29481827

Auteurs

T Cameron Wild (TC)

School of Public Health, University of Alberta, Edmonton, Alberta, Canada.

Jakob Koziel (J)

School of Public Health, University of Alberta, Edmonton, Alberta, Canada.

Jalene Anderson-Baron (J)

School of Public Health, University of Alberta, Edmonton, Alberta, Canada.

Mark Asbridge (M)

Department of Community Health and Epidemiology, Department of Emergency Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

Lynne Belle-Isle (L)

Canadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.

Colleen Dell (C)

Department of Sociology, School of Public Health, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.

Richard Elliott (R)

Canadian HIV/AIDS Legal Network, Toronto, Ontario, Canada.

Andrew Hathaway (A)

Department of Sociology and Anthropology, University of Guelph, Guelph, Ontario, Canada.

Donald MacPherson (D)

Canadian Drug Policy Coalition, Vancouver, British Columbia, Canada.

Keely McBride (K)

Alberta Health, Edmonton, Alberta, Canada.

Bernie Pauly (B)

Canadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.

Carol Strike (C)

Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Adam Galovan (A)

Department of Human Ecology, University of Alberta, Edmonton, Alberta, Canada.

Elaine Hyshka (E)

School of Public Health, University of Alberta, Edmonton, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH